11/9/2026

speaker
Conference Operator
Operator

Welcome to Amaro Inc.'s third quarter 2026 conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to Shannon Devine, Investor Relations. Thank you. You may begin.

speaker
Shannon Devine
Investor Relations

Good afternoon and thank you for joining Amero's third quarter 2026 earnings call. I am Shannon Devine. Joining me today are Hank Holland, Amero's chairman and chief executive officer, and Brett Paduch, Amero's chief financial officer. Earlier this afternoon, Amero issued its earnings release and posted its earnings presentation, both of which are available on the investor relations section of the company's website. Before we begin, please note that today's discussion will contain forward-looking statements regarding Amero's business, financial performance, outlook, and future operating plan. Actual results may differ materially from those discussed today. Please refer to Amero's earnings materials and SEC filings for discussion of factors that could cause actual results to differ. Any forward-looking statements that are made on this call speak only as of the date of this call, and Amero disclaims any obligation to update any forward-looking statements except as required by law. certain non-GAAP financial measures will also be discussed. Information regarding Amero's non-GAAP financial measures, including reconciliations to the most directly comparable GAAP measures, can be found in Amero's earnings release and supplemental materials available on Amero's investor relations website. With that, I will now turn the call over to Hank.

speaker
Hank Holland
Chairman and Chief Executive Officer

Thank you, Shannon. Welcome. Good afternoon and thank you for joining us. And good morning to those joining from Australia. Welcome to Amero's third quarter 2026 earnings conference call and the inaugural earnings call as a NASDAQ listed company. Our first earnings call as a NASDAQ listed company also marks our first results reported in U.S. dollars under U.S. GAAP. So comparative figures may differ from those we previously reported on the ASX, where our CDIs continue to be co-ordinated under the symbol 3DA. To our new shareholders, welcome and thank you for your confidence. to our longstanding shareholders, thank you for your support over the past four and a half years. Because many of you are new to Amero, I want to begin with a bigger picture. The opportunity in front of us, why we believe that Amero has a differentiated market position, and why we believe the company is at an inflection point. That will highlight the financial results in the third quarter and revenue guidance for the fourth quarter. Then Brett will take you through the financials in more detail. Amaro sits at the intersection of three enduring themes, rebuilding the U.S. defense industrial base, reshoring and scaling sovereign manufacturing, and the adoption of additive and advanced manufacturing. For the first time in decades, aerospace and defense are simultaneously experiencing peak demand. The Columbia and Virginia class submarine programs, the advent of hypersonic weapons, the replacement of the Minuteman ICBM with Sentinel, and the build out of missile defense are driving generational investment. At the same time, the war in Ukraine exposed how thin our domestic capacity is in large castings and forgings, among the most constrained links in the defense supply chain. I want to emphasize all these themes are structural, not cyclical. The United States allowed its defense industrial base to atrophy over three decades, rebuilding it and bringing critical supply chains home is both the national security imperative and sound economic policy. AMIRA's corporate strategy has been driven by a demand pull that's a direct result of these thematic forces. Within that backdrop, AMIRA addresses two specific bottlenecks. The first and high value spherical metal powders. Powders are consumable of metal 3D printing, the ink cartridge to the printer. So as the installed base of metal 3D printers expands, powder demands expands with it. it's a pick and shovel business. Titanium alloy powder serve defense, aerospace, medical, and consumer applications. Refractory alloy powders such as Niobium C103 serve high temperature applications and high growth verticals that include the defense, space, and nuclear energy sectors. The second is PMHIP or powder metallurgy hot isostatic pressing. A mature technology that was developed over seven decades ago and has the benefit of military specifications and mature data sets. AMERA's technical team has done much of the pioneering work over the past two decades for producing large, complex, near net shaped parts as an alternative to constrain castings and forgings. We estimate the U.S. addressable market across our three product lines at approximately 737 million in 2026, growing to approximately 1.5 billion by 2030. that's large enough to build a significant business, yet specialized enough to attract limited competition, which supports a specialty margin structure. As the largest shareholder, that combination is the thesis that led to my investment into Amero, and it continues to guide our forward-leaning strategy. Amero has commissioned the largest U.S. domestic production capacity for titanium and refractory alloy spherical powders, co-located with PMHIP Manufacturing and AS9100D certified facility near Chattanooga, Tennessee. The competitive landscape is narrow. In titanium powder, our two primary competitors operate in Canada. We have no primary competitor in the United States. In refractory powders, we have one primary competitor. In PMHIP, others make simple parts, but our proprietary know-how and experience with complex near net shape components is highly differentiated. Our advantage rests on three things that are difficult to replicate. First, technology and know-how. We operate IGA premium atomizers, a crucible-free process that the Air Force Research Laboratory has called the industry standard for reactive and refractory materials. But equipment alone does not make commercially viable powder. Our technical team, anchored by Eric Bono, our chief technology officer, has made modifications to the equipment and optimized the process parameters to deliver roughly twice the usable yield while consuming about half the argon gas of conventional atomizers. That matters because yield determines how much feedstock and labor go into every kilogram of sellable powder. Our two largest variable cost, and argon is a significant input of its own right. Our argon recycling system targets a further reduction argon cost of at least 77%. Second, qualifications. The highest barrier to new entries, and to production contracts. Our C-103 has been qualified to a manned space flight standard. And we've closely collaborated with the US Navy, BPMI and the Naval Nuclear Propulsion Program for development, first articles and qualification of critical submarine components. Third, customer relationships built on demand pull. Shortly after we moved to Tennessee, we committed to dedicate an IGA premium atomizer to refractory alloys, including niobium, tungsten, and Malibu. This was a direct response to the long lead times from a sole supplier that was slowing down the development of hypersonic programs. Months later, we began close collaboration with leading stakeholders in Naval Nuclear Propulsion Program, developed PMHIP as a substitute for long lead time forging. Following a roundtable convened at our facility last December, the Navy's Maritime Industrial Base Program Office issued a formal letter of support validating our PMHIP manufacturing as a viable and technically ready alternative casting and forgings. In July, we received our first low-rate initial production contract with BPMI. On the commercial side, we've structured long-term agreements with leaders in high-growth verticals, several naming Amero as exclusive supplier. And in July, we were awarded a $4.5 million Department of War contract to develop alternative refractory alloy powders that reduce cost and reliance on foreign raw materials. As other companies are beginning multi-year capital programs to address these bottlenecks, we have largely completed ours. Amero is now shifting from build-out to scaling production. Through September 30th, we had invested $52.2 million in plant and equipment. We operate three IGA premium atomizers with approximately 680 metric tons of annual capacity. 480 metric tons of titanium and 200 metric tons refractory. And our fourth atomizer expected in June, 2027 takes total capacity to 920 metric tons. In August, we commissioned a custom designed titanium sieving system that together with our third atomizer doubled our titanium throughput capacity. In our first full year commercial production, the 12 months ended June 30th. We generated 12.5 million in revenue, Trailing 12-month revenue through September 30th was $13.5 million, up 191%. And our backlog as of September 30th of $13.4 million is roughly equal to that. Because our fixed production costs are largely in place, we expect revenue growth to drive operating leverage. I also want to directly address safety. Following safety incidents earlier this year, we committed to lean in. We paused titanium production and completed a comprehensive process system and facility safety review with Jensen Hughes, a leader in safety, dust hazard, and risk-based engineering. We engaged Jensen Hughes to identify risk mitigation strategies that were utilized by larger scale industrial operations with dust hazards, such as the sugar industry, paper mills, and grain operations. We implemented resulting improvements. and titanium production resumed in late July after approximately six week pause. No order cancellations and no employee attrition. As for Q3 highlights and outlook. Turning to the quarter. Third quarter revenue grew 35% to 4.1 million, landing near the top of the previously disclosed range. And nine month revenue grew 170% to 11.5 million. We ended the period with a backlog of $13.4 million, an increase of 180% from September 2025, and approximately 100% of trailing 12-month revenue. Operating cash used for the quarter fell $1 million year-over-year to $6.3 million. Commercially, the Department of War Award and our first BPMI contract advanced both of our production lines in defense, refractory powders and PMHIF. Operationally, we restarted titanium production and doubled titanium throughput capacity with commissioning and expanded custom-designed fabricated sieving system. And in the capital markets, we began trading on NASDAQ on October 15, receiving aggregate net IPO proceeds of $17.0 million and amended our Ex-Im Bank Credit Agreement to release $2.1 million of restricted cash and move the liquidity covenant test to 2028. As of October 31, we had $19.3 million of cash and cash equivalents after October operating cash use and capital expenditures. Today we are issuing our first formal guidance as a U.S. listed company. We expect Q4 2026 revenue of $4.5 to $5.0 million, which would result in a quarterly increase of 121% to 146% year over year, Combined with our results to date, that would result in full year 2026 revenue of $16.0 to $16.5 million, up 154% to 162%. Our priorities are clear. Convert backlog into revenue, expand the breadth and depth of our commercial partnerships, and bring argon recycling and our fourth atomizer online in the first half of 2027. With that, I'll turn it over to our CFO, Brett, to provide more detail on our financial results.

Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-

Use this data in your own app

Pull this call's transcript, audio and slides with the Earnings call transcripts API.

See pricing

9,000+ companies · REST API

Investor presentation